Csenge Advisory Group

SEC CIK: 0001715593
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overview All 13F holders of BCRX Full Q2 2026 holdings

Shares (Q2 2026): 25,000
Value: $250.0K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of BCRX by Csenge Advisory Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	25,000	$250.0K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	25,000	$238.0K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	25,000	$195.0K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	25,000	$189.8K	<0.1%	+25,000	New	Holders